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 1. Materials 
N-(5-hexynyl)phthalimide, N-hydroxysuccinimide, methyl bromoacetate, trifluoroacetic anhydride, 
tetraethyl ammo nium bicarbonate, tris(2-carboxyethyl)phosphine, and bovine ubiquitin were obtained 
from Sigma-Aldrich Co. (St. Louis, MO). The hydrophilic ligand, tris[(hydroxyethyl-
triazolyl)methyl]amine (TBTA-OH) was a kind gift from the Sharpless and Fokin groups at the Scripps 
Research Institute. The model peptides, Ac-AAKAAAAAKAR and Ac-AAAAKAAAAAR (98% 
purity), were obtained from Biomer-Tech (Pleasanton, CA). Yeast cell lysate was a generous gift from 
the Coon group at the University of Wisconsin, Madison. Monomeric avidin resin kit was purchased 
from Pierce (Rockford, IL). Biotin-(PEG)3-azide was acquired from Berry & Associates, Inc. (Dexter, 
MI). Sequencing-grade trypsin was obtained from Promega (Madison, WI). OMIX-C18 desalting tips 
(100 µL scale) were purchased from Varian, Inc. (Palo Alto, CA). Microcon YM-3K spin filter units, 
nitrocellulose membrane, and C18-ZipTip (10 µL scale) were purchased from Millipore (Billerica, MA). 
Microspin SCX columns were acquired from the Nest Group, Inc. (Southborough, MA). High-capacity 
neutravidin agarose resin, n-dodecyl-β-D-maltoside, and supersignal west pico chemiluminescent 
substrate were from Thermo Scientific (Rockford, IL). Lysyl endopeptidase (LysC) was from Wako 
Chemicals USA (Richmond, VA). Cell culture reagents, Flip-In T-REx 293 cells, plasmids, and 
monoclonal antibodies for Cul1 (322400), Skp2 (323300), and Skp1 (323800) were from Invitrogen 
(Carlsbad, CA), and that of Cand1 (sc-10672) was from Santa Cruz Biotechnology (Santa Cruz, CA). 
Plasmid DNA containing the human Cul1 sequence was purchased from Open Biosystems (Huntsville, 
AL). MLN4924 was a generous gift from Millennium: The Takeda Oncology Company (Cambridge, 
MA). All other general chemicals for buffers were purchased from Fisher Scientific (Hampton, NH), 
EMD (Gibbstown, NJ), VWR International (West Chester, PA), and Sigma-Aldrich (St. Louis, MO). All 
chemicals mentioned above were used as received without further purification. 
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2. Synthesis of the Clickable Cross-Linker (CXL) 
Overall synthetic steps are summarized in Scheme S1.  
 
Scheme S1 
6-Amino-hex-1-yne (1). The amino alkyne was prepared from 2-(hex-5-ynyl)isoindoline-1,3-dione and 
hydrazine as described in the literature without modification.
1
 The crude product was purified by flash 
chromatography (silica gel, dimethylene chloride:methanol = 3:1 ~ 1:1) to yield 6-amino-hexyne as a 
pale greenish yellow oil. Yield: 30%. 
1
H NMR spectra is reproduced with the previous report.
2
 ESI-MS 
[M+H]
+
 m/z 98.1.  
Dimethyl 2,2'-(hex-5-ynylazanediyl)diacetate (2). The 6-amino-hex-1-yne (0.3 g) was added to the 
stirring solution of 20 mL THF, 2 eq K2CO3, and 2.4 eq methyl bromoacetate. The mixture was further 
stirred at room temperature for 3 h under a stream of dry N2. The reaction was monitored by thin layer 
chromatography (TLC) using n-hexane:ethyl acetate (= 2:1) as the mobile phase, and the mixture was 
filtered after completion of the reaction. The filtrate was concentrated and purified by flash 
chromatography (silica gel, n-hexane:ethyl acetate = 1:1). The final product, dimethyl 2,2'-(hex-5-
ynylazanediyl)diacetate, was concentrated by rotary evaporation and acquired as a transparent oil. Yield: 
59%. ESI-MS [M+H]
+
 m/z 242.1, 
1
H NMR (CDCl3)  3.71 (s, 6H), 3.56 (s, 4H), 2.73 (t, 2H), 2.22 (m, 
2H), 1.94 (t, 1H), 1.57 (m, 4H). 
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2,2'-(Hex-5-ynylazanediyl)diacetic acid (3). To the obtained ~1.4 g dimethyl 2,2'-(hex-5-
ynylazanediyl)diacetate was added 20 mL THF and 20 mL of 2 M KOH. The mixture was stirred 
overnight and monitored by TLC. The organic layer was separated, and the aqueous layer was quenched 
by addition of 20 mL of 2 M HCl. The solvent (H2O) was completely removed by rotary evaporation, 
and the resulting solid was dissolved in acetonitrile (ACN). The insoluble KCl salt was filtered, and the 
filtrate was concentrated by rotary evaporation. The final product of free acid was obtained as a greasy 
transparent oil. Yield: quantitative. ESI-MS: [M+H]
+
 m/z 214.1. To obtain the hydrochloride salt, an 
additional 10 mL of 2 M HCl was added before removal of the solvent. Dimethyl formamide (DMF, 3 × 
30 mL) was added to the resulting solid and filtered. The hydrochloride salt was obtained as a white 
solid after concentration under reduced pressure. Yield: quantitative. 
NHS-activated 2,2'-(hex-5-ynylazanediyl)diacetic acid (CXL). N-hydroxysuccinimide trifluoroacetate 
was prepared by stirring N-hydroxysuccinimide (NHS) and 4 eq trifluoroacetic anhydride for 5 h. The 
mixture was concentrated under reduced pressure and further dried under high vacuum overnight. The 
product was obtained as a white, highly hygroscopic solid and stored in an anhydrous desiccator before 
use. The obtained ~1.1 g 2,2'-(hex-5-ynylazanediyl)diacetic acid was activated by 2.4 eq N-
hydroxysuccinimide trifluoroacetate in 10 mL anhydrous DMF under a stream of dry N2. The mixture 
was stirred overnight and monitored by TLC using n-hexane:ethyl acetate (= 2:1) as the mobile phase. 
After completion of the reaction, the mixture was concentrated to ~500 µL by rotary evaporation and 
subjected to flash chromatography using n-hexane:ethyl acetate (= 2:1) as the mobile phase. The final 
product, NHS-activated 2,2'-(hex-5-ynylazanediyl)diacetic acid (CXL) was concentrated by rotary 
evaporation, and obtained as a pale yellow oil. Several 200 µL aliquots of 50 mM stock solution 
dissolved in anhydrous dimethyl sulfoxide (DMSO) were prepared and stored at –80 °C. The sealed 
stock aliquots were opened immediately before use, and NHS activation was verified by ESI-MS in 
100% ACN. ESI-MS [M+H]
+
 m/z 408.1, [M+Na]
+
 m/z 420.0. (Note: the reaction yield can be improved 
by adding a stoichiometric equivalent of triethylamine for NHS activation.)  
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3. Cross-Linking of a Model Peptide 
A 50 µg portion of the model peptide, Ac-AAKAAAAAKAR  or Ac-AAAAKAAAAAR (98% 
purity) was dissolved in 50 µL of HPLC-grade H2O.  A mixture of 5 µL CXL stock solution (10 µg/µL 
in DMSO), 5 µL Ac-AAKAAAAAKAR or Ac-AAAAKAAAAAR stock solution (10 µg/µL), and 15 
µL ACN was prepared.  The mixture was allowed to react at room temperature for 1 h. The reaction was 
terminated by adding 5 µL formic acid (FA). The solvent was completely removed in vacuo, and the 
residue was reconstituted in 100 µL of 0.1% FA (aq) with additional 2 µL FA to further acidify. The 
resulting solution was desalted using an OMIX-C18 tip (100 µL capacity) following the standard 
procedure. The cross-linked peptide (~50 µg) was eluted in 100 µL solution of 0.1% FA, 50% ACN and 
50% H2O and 5 µL of the eluted cross-linked peptide solution was diluted to 5 µM and analyzed by a 
LCQ ion trap mass spectrometer. The remaining cross-linked peptide solution was dried for click 
reaction. 
CuAAC with the biotin-(triethyleneglycol)-azide (biotin-(PEG)3-azide) was performed as follows: Ten 
micrograms of the CXL cross-linked model peptide were dissolved in 100 mM tetraethyl ammonium 
bicarbonate (TEAB) (pH = 8.5), containing 250 µM hydrophilic ligand tris[(hydroxyethyl-
triazolyl)methyl]amine (TBTA-OH), 2.5 mM CuSO4·5H2O, 5 mM tris(2-carboxyethyl)phosphine 
(TCEP) hydrochloride and 1 mM biotin-(PEG)3-azide in a total volume of 100 µL 1% (v/v) DMSO final. 
The mixture was reacted for 2 h with gentle mixing at 37 °C and quenched by 5% FA (aq). The solvent 
was removed in vacuo and the residue was desalted using OMIX-C18 tip as described above. The eluent 
was diluted to 10 µM with 0.1% FA, 50% ACN and 50% H2O and directly infused to the LCQ ion trap 
mass spectrometer for analysis.  
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4. Cross-Linking of Ubiquitin  
The general reaction summary of cross-linking of ubiquitin (PDB ID: 1UBQ) is shown in Scheme 1.  
Twenty micrograms of ubiquitin were dissolved in 200 µL of 1X PBS (pH = 7.4) and 1.2 µL of 50 mM 
CXL stock solution in DMSO was added and reacted for 30 min at room temperature. The reaction was 
quenched by 50 µL of 100 mM Tris-HCl buffer (pH = 8.5) and incubated for 15 min. The cross-linked 
ubiquitin was concentrated to ~30 µL and the buffer was exchanged to 100 mM ammonium bicarbonate 
(pH = 8.5) using Microcon YM-3K spin filter units. The trypsin digest reaction volume was adjusted by 
adding 185.5 µL of 100 mM ammonium bicarbonate buffer containing 2 M urea and 2.5 µL of 100 mM 
CaCl2. Two microliters of 0.5 µg/µL trypsin in 5 mM acetic acid (proteins:trypsin = 20:1 w/w) was 
added and incubated for 15-18 h at 37 °C. The reaction was terminated by addition of 5% FA (aq). The 
resulting tryptic digest was desalted using OMIX-C18 tip and a 1 µg portion was injected into a 
nanoLC-LTQ-FTICR mass spectrometer for analysis. 
Forty micrograms of the cross-linked tryptic digest of ubiquitin were subjected to click reaction by 
combining resulting peptides from two identical cross-linking experiments. The desalted tryptic digest 
was dissolved in 100 mM TEAB, containing 250 µM hydrophilic ligand TBTA-OH, 2.5 mM 
CuSO4·5H2O, 5 mM TCEP hydrochloride and 1 mM biotin-(PEG)3-azide in a total volume of 100 µL 
1% (v/v) DMSO final. An additional sample was prepared by mixing 50 µg cross-linked digest of 
ubiquitin with 50 µg yeast cell lysate and subjected to identical click reaction conditions to demonstrate 
enrichment from a complex sample. Mixtures were reacted at 37 °C for 12 h with gentle shaking. 
Reactions were quenched by addition of 5% FA (aq). 
Microspin SCX columns (200 µL scale, with 50 µL of the bed volume for SCX material) were used 
for removal of excessive TBTA-OH and biotin-(PEG)3-azide. A 10 µg portion of the peptides from the 
click reaction (25 µL) was dried to completeness in vacuo and the residue was reconstituted with 0.5% 
FA, 5% ACN (aq). Microspin SCX columns were prepared by applying 4 bed volumes (200 µL) of 
methanol then H2O, respectively. Activation of the SCX material was performed by treatment with 200 
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µL of 500 mM ammonium acetate for 1 h at room temperature. After activation, the spin columns were 
washed with H2O and equilibrated with 0.5% FA, 5% ACN (aq). The peptide sample solution was 
applied to the spin column and flushed twice to bind completely. The spin column was washed with 400 
µL of 0.5% FA, 5% ACN (aq), which corresponds to at least 8 bed volumes of the SCX material. The 
peptides were fractionated with 400 µL of 50, 250, and 500 mM ammonium acetate in 0.5% FA, 25% 
ACN (aq), and additional 500 mM ammonium acetate solution was used for complete elution of highly 
charged cross-linked peptides. Each fraction was desalted using C18-ZipTip following manufacturer 
instructions, and eluents were dried in vacuo. The residues were reconstituted with 5 µL of 0.2% FA 
(aq) and injected to a nanoLC-LTQ-FTICR mass spectrometer for analysis. 
Monomeric avidin-biotin affinity chromatography was performed using the batch style procedure 
according to the manufacturer manual with minor modifications. Peptide samples after click reaction 
were eluted without SCX fractionation using either 500 mM ammonium acetate in 0.5% FA, 25% ACN 
(aq) or 50 mM ammonium acetate in 0.1% TFA, 25% ACN (aq). The SCX eluents were dried in vacuo 
and reconstituted with 1X PBS to the same concentration range used in the cross-linking reaction. By 
batch incubation of the mixture of the monomeric avidin resin and peptide samples at room temperature 
or 4 °C for 12 h under gentle mixing, the biotin-PEG3-azide conjugated peptides were bound to 
monomeric avidin. Unmodified peptides were removed by flushing the resin with 4 bed volumes of PBS, 
100 mM Tris-buffer (pH = 7.4), 100 mM ammonium bicarbonate (pH 7.4) and water, respectively. The 
final products of interest were eluted by 0.4% TFA, 50% ACN (aq). An aliquot of the eluent was 
analyzed by a nanoLC-LTQ-FTICR mass spectrometer. 
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5. In vivo Cross-linking of Cul1 
The in vivo cross-linking of HEK 293 cells by CXL, followed by Western blot analysis were carried 
out as described previously with minor modifications.
3
 Briefly, to facilitate the purification of Cul1, a 
HEK 293-derived stable cell line capable of expressing tagged Cul1 upon tetracycline treatment was 
constructed using the T-REx
TM
 (Tetracycline-regulated Expression) system (Invitrogen, Carlsbad, CA). 
The tandem tag we adopted consists of a hexa-histidine sequence and a biotinylation signal sequence.
4
 
Biotinylation is catalyzed by endogenous biotin ligases, which are present in all eukaryotic cells.
5
 A 
specific lysine residue in the biotinylation signal sequence functions as an acceptor site for biotin in 
vivo.
6
 
Tagged Cul1 was induced with 1.0 µg/mL tetracycline for 4 h in experiments for in vivo cross-linking. 
Twenty four hours after induction, cells were washed by 1X PBS and subject to in vivo cross-linking by 
treatment with 0, 0.2, 0.5, and 1.0 mM of CXL, and 0.2 and 0.5 mM of disuccinimidyl suberate (DSS), 
respectively and incubated for 1 h at 37 C. After completion of the cross-linking, unreacted cross-
linkers were quenched by 12.5 mM glycine buffer in 1X PBS (pH = 7.4) for 10 min at room temperature. 
Cross-linked cells were harvested and lysed for 30 min at 4 C with the lysis buffer (0.050 M HEPES, 
pH 7.5, 0.0050 M Mg(OAc)2, 0.070 M KOAc, 10% glycerol, and 0.4% IGEPAL CA630). The lysate 
was centrifuged at 16,600 g at 4 C for 20 min and a portion of the supernatant was used for Western 
blot analysis against Cul1. The remaining lysates were immuno-precipitated with Neutravidin agarose 
resin (Thermo Scientific) for 1 h at room temperature followed by three washing steps with lysis buffer. 
Recovered Cul1
THBH
 and cross-linked proteins were eluted from the resin by boiling in 2× Laemmli 
sample buffer, separated by SDS-PAGE and transferred to nitrocellulose membrane (Millipore). 
Proteins were detected with antibodies directed against Cul1 (322400, Invitrogen), Cand1 (sc-10672, 
Santa Cruz Biotechnology), Skp2 (323300, Invitrogen), or Skp1 (323800, Invitrogen) using SuperSignal 
West Pico Chemiluminescent Substrate (Thermo Scientific). 
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6. Circular Dichroism Spectrometry 
The CXL cross-linked ubiquitin samples were analyzed by an Aviv Model 62A DS Circular 
Dichroism (CD) Spectrometer (Lakewood, NJ) at room temperature. The critical instrumental 
parameters included: acquisition range = 200 to 300 nm, step size = 1.00 nm, averaging time = 5 s, 
bandwidth = 1 nm, and path length = 1 mm. One scan was recorded for each spectrum. For CXL cross-
linked samples, 1 to 4 µL of 50 mM CXL stock solution in DMSO was added to 196 to 199 µL of 0.1 
mg/mL ubiquitin in 1X PBS pH 7.4 to result in a final concentration of 0.25 to 1 mM CXL in 200 µL. 
CD spectra were collected upon addition of CXL (t = 0) and after 30 min of cross-linking reaction (t = 
0.5 h). 
Figure S1. CD spectra of CXL cross-linked ubiquitin. 
 
CD provides a very useful and fast analytical technique for analysis of secondary structure, folding, 
and binding properties of peptides and proteins.
7
 The CD spectra of native ubiquitin were previously 
recorded, yielding the secondary structure analysis of 6% α-helix, 10% β-sheet and 84% random 
structures, which can be observed as increasingly negative ellipticity over the range of 225 to 240 nm.
8
 
Figure S1 depicts the CD spectra of ubiquitin cross-linked by various concentrations and reaction times 
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of CXL. No significant changes are observed among ubiquitin samples that are native (black), cross-
linked at 0.25 mM (red, t = 0; blue, t = 30 min) or 1 mM CXL (green, t = 0; pink, t = 30 min). Abundant 
peaks from 220 to 230 nm result from the increased DMSO proportion in 1 mM CXL cross-linked 
ubiquitin samples (from 1% to 4%). The CD signal fluctuation in 1 mM CXL experiments is mainly 
caused by light scattering due to the increased concentrations of small molecules such as the CXL cross-
linker and DMSO. 
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7. Mass Spectrometry 
The CXL cross-linked Ac-AAKAAAAAKAR and Ac-AAAAKAAAAAR model peptide were 
analyzed by a LCQ-deca XP ion trap mass spectrometer (Thermo Fisher Scientific, San Jose, CA). The 
sample was directly infused by the standard electrospray ionization source with a constant flow at 3 
µL/min. The critical instrumental parameters were set up as follows: the spraying voltage at 3.5 kV, 
capillary voltage at 39 V, capillary temperature at 275 °C, and tube lens voltage at −60 V. Fifty scans 
were recorded for each spectrum. 
For collision induced dissociation, the cross-linked peptides from ubiquitin were analyzed by a 
nanoflow HPLC (Waters Co.) coupled on-line via a home-built nanoelectrospray
 
ion source to a LTQ-
FTICR mass spectrometer (Thermo Fisher Scientific). Samples in 5 µL of 0.2% FA (aq) were loaded 
onto
 
a C18-reversed phase column (15 cm long, 100 µm inner diameter,
 
packed in-house with Magic 
C18-AQ 5 µm resin from Michrom Bioresources, in
 
solvent A (2% ACN, 0.2% FA) with a flow rate of 
250 nL/min for 24 min and eluted
 
with a linear gradient from 0% to 36% solvent B (98% ACN, 0.2% 
FA) over 110 min, followed by 10 min at 100% solvent B, at a flow rate of 250 nL/min. The column 
was re-equilibrated with solvent A. Mass spectra were acquired in the positive ion mode applying
 
data-
dependent acquisition with automatic switching between survey scan and tandem
 
mass spectrum 
acquisition. Samples were analyzed
 
with a “top 10” method; acquiring one FTICR survey scan in the 
mass range of m/z 400–1600 followed by MS/MS of the ten most intense ions in the LTQ. The target ion 
value in the LTQ-FTICR
 
was 500,000 for survey scan at a resolution of 50,000 at m/z
 
400. 
Fragmentation in the LTQ was
 
performed by CID with a target value
 
of 5,000 ions. Selected
 
sequenced 
ions were dynamically excluded for 30 s. Critical mass spectrometric parameters were: spray
 
voltage, 2.4 
kV; no sheath and auxiliary gas flow;
 
ion transfer tube temperature, 200 °C; normalized
 
collision energy 
(35%) for MS/MS.  
For electron transfer dissociation, cross-linked peptide samples were loaded and washed on a 100 μm 
× 35 mm CVC MicroTech (Fontana, CA) C18 trap before chromatographic separation was performed 
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on a New Objective Halo C18 75 μm × 100 mm, 90 Å, 2.7 μm (Woburn, MA) column using mobile 
phases of 0.1% FA in water (solvent A) and ACN containing 0.1% FA (solvent B). Peptides were eluted 
from the column at a flow rate of 300 nL/min using an Eksigent nanoLC 2D pump (Dublin, CA) with a 
110 min gradient (0-30% phase B over 90 min, 30-80% phase B over 20 min). The HPLC system was 
coupled to an LTQ-Orbitrap XL mass spectrometer and the source conditions were as follows: capillary 
temperature, 180 ºC; capillary voltage, 49 V; ESI spray voltage, 1.8 kV. The automatic gain control 
target was fixed at 5 × 10
5
 ions for MS and 1 × 10
4
 for MS/MS scans. The instrument was operated in 
the data-dependent acquisition (DDA) mode, with MS survey scan (m/z 300-2000) performed in the 
Orbitrap using a resolution set at 60,000. Parent ions with ions of charge state +1 were rejected for DDA 
MS
2
 using charge-state screening. CID activation was performed on the 4 most abundant ions over 
10,000 counts using normalized collision energies of 35, an activation Q of 0.250, and an activation 
time of 30 ms followed by detection using the linear ion trap. ETD activation was also performed on the 
4 most abundant ions (over 50,000 counts) using a reaction time of 125 ms, a default charge state of +2, 
and charge state dependent ETD time with supplemental activation enabled. The ETD emission current 
used was 785 µA, and the electron energy was set at 70 eV. The CI gas pressure and source temperature 
were 9 psi and 160 ºC, respectively. Ions with masses within 10 ppm of previously fragmented ions were 
excluded from DDA for 30 s. 
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8. LC-MS Elution Profiles Analysis 
Sample Clean-up Following Click Reaction 
CuAAC is a widely used bioconjugation reaction. However, seamless integration of CuAAC into the 
downstream proteomics workflows can be challenging due to the persistence of residual chemical 
reagents such as copper ions, hydrophobic ligands, and coupling reagents (azide or alkyne).
9,10
 Those 
impurities often adversely impact the ionization efficiency of target peptides. Effective sample clean-up 
procedure after CuAAC is therefore very important for successful sample analysis by MS.  
For this purpose, we adopted SCX, followed by C18 desalting procedures for the removal of non-ionic 
species following CuAAC. The hydrophobic ligand reagent also has been replaced by its hydrophilic 
counterpart, tris[(hydroxyethyl-triazolyl)methyl]amine (TBTA-OH). Poor binding of TBTA-OH to the 
C18 matrix would result in its effective removal via C18 desalting column. Copper ions can be removed 
during the same desalting step. 
Figures S2a-c and Figure 4 in the main text show LC-MS profiles of ubiquitin cross-linked peptide 
samples following CuAAC. TBTA-OH was not detected in any LC-MS profile, confirming its 
successful removal. Excess biotin-(PEG)3-azide molecules were mostly removed by SCX clean-up due 
to their poor interaction with the SCX matrix, but were not completely eliminated (Figures S2a-c). The 
protonated biotin-(PEG)3-azide (m/z 445.2) was eluted along with peptides (retention time around 55 
min in Figure S2a and 46 min in Figures S2b and S2c), but the mass-to-charge ratio did not overlap with 
those of other cross-linked peptides, ensuring no interference with the sequencing. Based on its ion 
signal, the residual amount of biotin-(PEG)3-azide after SCX clean-up was tolerable as it did not 
significantly suppress peptide ionization (Figures S2b and S2c), especially for cross-linked peptides that 
were eluted mostly in the SCX fractions at 250 and 500 mM salt concentrations (Table S2). For 
complete removal of the residual azide affinity tags, cleavable biotin tags
11
 can be employed along with 
streptavidin-conjugated magnetic resin, which is expected to suffer less nonspecific binding than 
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monomeric glycosylated avidin.  This may allow us to enhance the elution purity via the chemical 
cleavage of affinity tags.  
Peptide Fractionation by SCX 
Highly-charged species tend to more strongly bind to SCX matrix. Therefore, SCX can be used for 
sample fractionation by discriminating the charge states of analytes. Primary sample fractionation by 
SCX was demonstrated for sensitive detection of cross-linked peptides from abundant linear peptides by 
Rinner et al.
12,13
 For the present study, peptide fractionation of ubiquitin cross-linked peptides was 
performed by sequential increase of the salt concentration during the SCX elution step. Figures 4a-e in 
the main text show LC-MS total ion current (TIC) chromatograms of differentially eluted ubiquitin 
cross-linked peptide samples by applying salt gradients, 50 mM, 250 mM, 1st 500 mM, and 2nd 500 
mM ammonium acetate, 0.5% FA, respectively (Figure 4b-e), or direct elution using 500 mM 
ammonium acetate, 0.5% FA with no fractionation (Figure 4a). As summarized in Tables S1 and S2, 
highly charged cross-linked peptides were eluted in the high concentration region. However, some of the 
cross-linked peptides were also co-eluted with other linear peptides at 250 mM salt concentration (Table 
S2, Figure 4c). Thus, marginal separation of cross-linked peptides was achieved by SCX fractionation. 
For further optimization of the separation, (an) additional elution step(s) using intermediate salt 
concentrations between 50 to 250 mM can be performed. Due to the low complexity of the ubiquitin 
cross-linked sample, SCX fractionation by itself is sufficient for separation and identification of cross-
linked peptides from other linear peptides (Figures 4a-e, Tables S1 and S2). As pointed out by Rinner et 
al.,
12
 however, the ultimate test for enrichment capability is found in the application of CXLs to higher 
complex systems such as in vivo cross-linking in eukaryotic cells. 
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Figure S2a. LC-MS elution profiles of ubiquitin cross-linked, clicked and SCX clean-up (single elution by 500 mM 
salt) 
 
Figure S1b. LC-MS elution profiles of ubiquitin cross-linked, clicked and SCX 50 mM elution 
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Figure S2c. LC-MS elution profiles of ubiquitin cross-linked, clicked and SCX 250 mM elution 
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9. xQuest Search 
The raw files from the LTQ-FTICR mass spectrometer were converted to Mascot generic format 
(MGF) files using ReAdW4Mascot (version 20090305a, available from the National Institute of 
Standards and Technology at http://peptide.nist.gov/software/ReAdW4Mascot2_20090305a.zip), and all 
but the 150 most intense fragment ions were filtered out. The cross-linked peptide search was performed 
using xQuest (http://prottools.ethz.ch/orinner/public/htdocs/xquest)
12
. The database search parameters 
were as follows: 0.5 Da fragment ion mass tolerance; 0.3 Da common fragment ion mass tolerance; 10 
ppm precursor ion mass tolerance; trypsin enzyme specificity (up to two missed cleavages); fixed 
carbamidomethyl (57.02146 Da) modification of cysteine; and variable modifications of methionine 
oxidation (15.99491 Da), cross-linked primary amines (177.07898 Da), mono-linked dead ends 
(195.08954 Da), cross-linked and biotin-(PEG)3-azide clicked primary amines (621.295568 Da), mono-
linked and biotin-(PEG)3-azide clicked primary amines (639.305584 Da), and reporter ion (525.28537 
Da). Both reporter ion-filtered and non-filtered MGF files by xQuest search were tested, but identical 
results were reported. Reduced MS/MS scans for xQuest search resulted in faster searching for the 
reporter ion-filtered MGF files. 
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10. X-ray Crystal Structure Analysis 
Human ubiquitin (PDB ID: 1UBQ. Note: the sequences of human and bovine ubiquitin are identical.) 
structure was analyzed by UCSF Chimera (version 1.5.3rc).
14
 For each pair of cross-linked lysine 
residue, the distances between the alpha carbons (Cα–Cα) and between nitrogens of ε-amines (NZ–NZ) 
were measured. 
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11. Tables of Cross-linked Peptides from xQuest Search 
Modified lysines in mono-linked peptides indicate solvent accessible residues. Intrapeptide cross-
linked peptides are generated by cross-linking of two lysine residues that are closely positioned, and 
which contain no unmodified lysine or arginine residues between them for tryptic cleavage. Interpeptide 
cross-linked peptides have one or more unmodified cleaved lysine or arginine residues between the 
cross-linked lysine residues, yielding two peptide chains covalently joined by the cross-linker. These 
interpeptide cross-linked peptides constrain the topology of surface exposed lysine residues, which is of 
particular interest for the construction of low resolution three-dimensional protein structures. Following 
tables are the summary of dead-end, intrapeptide and interpeptide cross-linked peptides observed from 
ubiquitin cross-linking experiments. 
Table S1. Dead-end and Intrapeptide Cross-linked Peptides from Ubiquitin. 
Sequence Before Click 
After Click & SCX 
Fractionation 
Reporter 
Ion 
1
MQIFV
6
K^TLTG
11
K Yes, 2+, 3+ Yes, 2+, 3+, 250 mM Yes 
7
TLTG
11
K^TITLEVEPSDTIENV
27
K Yes, 2+, 3+, 4+ Yes, 3+, 4+, 250 mM Yes 
12
TITLEVEPSDTIENV
27
K^A
29
K Yes, 3+ Yes, 3+, 250 mM Yes 
28
A
29
K^IQD
33
K Yes, 2+ No N/A 
28
A
29
K^IQDKEGIPPDQQ
42
R Yes, 3+ No N/A 
28
AKIQD
33
K^EGIPPDQQ
42
R Yes, 3+ Yes, 4+, 250 mM Yes 
30
IQD
33
K^EGIPPDQQ
42
R Yes, 2+, 3+ Yes, 2+, 3+, 250 mM Yes 
43
LIFAG
48
K^QLEDG
54
R Yes, 2+, 3+ Yes, 2+, 3+, 4+, 50, 250 mM Yes 
43
LIFAG
48
K^QLEDGRTLSDYNIQ
63
K Yes, 2+, 3+, 4+ Yes, 3+, 4+, 250 mM Yes 
55
TLSDYNIQ
63
K^ESTLHLVL
72
R Yes, 2+, 3+ Yes, 3+, 4+, 250 mM Yes 
1
MQIFV
6
K^TLTG
11
K^ Yes, 2+, 3+ Yes, 2+, 3+, 250 mM Yes 
28
A
29
K^IQD
33
K^EGIPPDQQ
42
R Yes, 2+, 3+ Yes, 3+, 250 mM Yes 
 
^: linked residues. Superscript numbers are the residue numbers of amino acids of ubiquitin.
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Table S2. Interpeptide Cross-linked Peptides from Ubiquitin. 
 chain  chain 
Before 
Click 
After Click & 
SCX 
Fractionation 
Reporter 
Ion 
Avidin 
Enrichment 
Cα 
distance 
(Ǻ) 
NZ 
distance 
(Ǻ) 
43
LIFAG
48
K^QLEDG
54
R 
1
MQIFV
6
K^TLTG
11
K 
Yes, 3+, 
4+, 5+ 
No N/A No 15.1 17.8 
1
MQIFV
6
K^TLTG
11
K 
55
TLSDYNIQ
63
K^ESTLHLVL
72
R 
Yes, 5+, 
6+ 
No N/A No 15.0 20.3 
30
IQD
33
K^EGIPPDQQ
42
R 
7
TLTG
11
K^TITLEVEPSDTIENV
27
K 
Yes, 4+, 
5+ 
Yes, 4+, 5+, 
250 mM, 1st 
500 mM, 2nd 
500 mM 
Yes Yes, 4+, 5+ 12.9 7.2 
43
LIFAG
48
K^QLEDG
54
R 
43
LIFAG
48
K^QLEDG
54
R 
Yes, 3+, 
4+, 5+ 
Yes, 5+, 2nd 
500 mM 
Yes Yes, 5+ N/A N/A 
43
LIFAG
48
K^QLEDG
54
R 
55
TLSDYNIQ
63
K^ESTLHLVL
72
R Yes, 6+ No N/A No 17.9 19.9 
28
A
29
K^IQD
33
K
 30
IQD
33
K^EGIPPDQQ
42
R
 
No No Yes Yes, 5+ 6.2 9.1 
 
^: cross-linked residues. Superscript numbers are the residue numbers of amino acids of ubiquitin.
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12. The Mechanism of Electron Transfer Dissociation of Cross-linked Peptides 
In the previously reported cross-linker by Chowdhury et al. (Click-enabled Linker for Interacting 
Proteins, or CLIP),
15
 the nitro group (NO2) is inserted for water solubility, and neutral loss of NO2 by 
CID can be used as a diagnostic peak. During ETD of cross-linked multiply charged peptide ions, due to 
the high hydrogen affinity of the nitro group, a nascent hydrogen atom produced by electron transfer can 
be immobilized, inhibiting the normal sequence of the fragmentation process.
16
 As model systems of 
CLIP and its hydrogen adduct, nitromethane (CH3NO2), its hydrogen attached radical (CH3NO2H·) and 
hydrogen atom were chosen. Initial geometry optimization and thermochemical calculations were 
performed by the B3LYP functional with the 6-311++G(d,p) basis set using Jaguar 7.5 (Schrödinger Inc., 
Portland, OR, USA). For odd electron species, open-shell configuration was employed. The refinement 
of single point energy was performed using (Q-Chem Inc., Pittsburg, PA, USA) at the CCSD(T)/6-
311++G(d,p) level of theory. Enthalpies of model systems were calculated from electronic energy, zero-
point energy and thermal contribution at 1 atm and 298.15K.  
The resulting nitronic radical stabilizes the charge-reduced species and prevents further fragmentation 
to form c- and z-type ions, yielding abundant charge-reduced species. With CXLs, there are no 
occurrences of specific chemical bonds or residues that can generate unexpected neutral losses or stable 
charge-reduced species in ETD, thus allowing efficient electron based dissociation processes to 
dominate. The enthalpy change in hydrogen attachment to nitromethane was obtained from enthalpy of 
each species, yielding 164 kJ/mol, which is larger than those of amide carboxyls (21-41 kJ/mol).
17
 The 
adiabatic electron affinity of niromethane was determined to be 0.172 ± 0.006 eV,
18
 which is not high 
enough to trap an electron in electron capture/transfer dissociation (ECD/ETD) of peptide ions.
16
 
Therefore, an electron from ECD or ETD to the CLIP cross-linked peptide ions is initially captured in 
high-lying Rydberg states, and undergoes the relaxation process to low-lying Rydberg states of positive 
charges (the Cornell mechanism) or Columb stabilized π* states of amide bonds (the Utah-Washington 
mechanism) via intermolecular electron transfer with internal conversion. Hydrogen transfer from a 
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hypervalent radical or proton transfer from any protonated sites yields aminoketyl intermediates whose 
bond dissociation energy (O–H) is much lower than the hydrogen affinity of nitromethane. Finally a 
labile hydrogen is scavenged by the nitromethane group, producing the relatively stable methyl nitronic 
radical in the charge-reduced cross-linked peptide ion.
16,19-21
 This leads to the inhibition of normal 
backbone fragmentation processes observed in ECD and ETD, yielding the poor sequence coverage. The 
recent studies have shown that ECD of highly charged (>2+) nitrated peptides and proteins produces c- 
and z-type backbone fragments with diminished intensities.
22-25
 This provides an explanation on the 
observation of some c and z ions in the ETD spectra of CLIP cross-linked peptides. 
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